Literature DB >> 33384958

Case Report: First in Human Online Adaptive MR Guided SBRT of Peritoneal Carcinomatosis Nodules: A New Therapeutic Approach for the Oligo-Metastatic Patient.

Luca Boldrini1, Angela Romano1, Lorenzo Placidi1, Gian Carlo Mattiucci1, Giuditta Chiloiro1, Davide Cusumano1, Veronica Pollutri1, Marco Valerio Antonelli1, Luca Indovina1, Maria Antonietta Gambacorta1, Vincenzo Valentini1.   

Abstract

Peritoneal carcinosis (PC) is characterized by poor prognosis. PC is currently treated as a locoregional disease and the possibility to perform very precise treatments such as stereotactic body radiation therapy (SBRT) has opened up new therapeutic perspectives. More recently, the introduction of Magnetic Resonance-guided Radiation Therapy (MRgRT) allowed online adaptation (OA) of treatment plan to optimize daily dose distribution based on patient's anatomy. The aim of this study is the evaluation of the effectiveness of SBRT OA workflow in an oligometastatic patient affected by PC. We report the clinical case of a patient affected by PC originating from colon cancer, previously treated with chemotherapy and surgery, addressed to OA SBRT treatment on a single chemoresistant PC nodule, delivered with a 0.35 T MR Linac. Treatment was delivered using gating approach in deep inspiration breath hold condition in order to reduce intrafraction variability. Prescription dose was 35 Gy in 5 fractions. The PTV V95% of the original plan was 96.6%, while the predicted values for the following fractions were 11.9, 56.4, 0, 0, and 61%. Similarly, the small bowel V19.5 Gy of the original plan was 4.63 cc, while the predicted values for the following fractions were 3.7, 8.6, 10.7, 1.96, 3.7 cc. Thanks to the OA approach, the re-optimized PTV V95% coverage improved to 96.1, 89.0, 85.5, 94.5, and 94%; while the small bowel V19.5 Gy to 3.36; 3.28; 1.84; 2.62; 2.6 cc respectively. After the end of RT, the patient was addressed to follow-up, and the re-evaluation 18F-FDG PET-CT was performed after 10 months from irradiation showed complete response. No acute or late toxicities were recorded. MRgRT with OA approach in PC patients is technically and clinically feasible with clean toxicity result. Online adaptive SBRT for oligometastases opens up new therapeutic scenarios in the management of this category of patients.
Copyright © 2020 Boldrini, Romano, Placidi, Mattiucci, Chiloiro, Cusumano, Pollutri, Antonelli, Indovina, Gambacorta and Valentini.

Entities:  

Keywords:  colorectal cancer; magnetic resonance guided radiation therapy; oligometastatic disease; online adaptive radiation therapy; peritoneal metastases; stereotactic body radiation therapy

Year:  2020        PMID: 33384958      PMCID: PMC7770165          DOI: 10.3389/fonc.2020.601739

Source DB:  PubMed          Journal:  Front Oncol        ISSN: 2234-943X            Impact factor:   6.244


  30 in total

1.  Stereotactic body radiation therapy: the report of AAPM Task Group 101.

Authors:  Stanley H Benedict; Kamil M Yenice; David Followill; James M Galvin; William Hinson; Brian Kavanagh; Paul Keall; Michael Lovelock; Sanford Meeks; Lech Papiez; Thomas Purdie; Ramaswamy Sadagopan; Michael C Schell; Bill Salter; David J Schlesinger; Almon S Shiu; Timothy Solberg; Danny Y Song; Volker Stieber; Robert Timmerman; Wolfgang A Tomé; Dirk Verellen; Lu Wang; Fang-Fang Yin
Journal:  Med Phys       Date:  2010-08       Impact factor: 4.071

Review 2.  Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies.

Authors:  Manuel J Koppe; Otto C Boerman; Wim J G Oyen; Robert P Bleichrodt
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

Review 3.  The role of radiotherapy in the treatment of peritoneal carcinomatosis.

Authors:  T Boterberg; W Duthoy; W De Neve
Journal:  Cancer Treat Res       Date:  2007

4.  Predicting tumour motion during the whole radiotherapy treatment: a systematic approach for thoracic and abdominal lesions based on real time MR.

Authors:  Davide Cusumano; Jennifer Dhont; Luca Boldrini; Giuditta Chiloiro; Stefania Teodoli; Mariangela Massaccesi; Bruno Fionda; Francesco Cellini; Luigi Azario; Jef Vandemeulebroucke; Marco De Spirito; Vincenzo Valentini; Dirk Verellen
Journal:  Radiother Oncol       Date:  2018-08-22       Impact factor: 6.280

5.  Peritoneal Metastases: Prevention and Treatment.

Authors:  Paul H Sugarbaker
Journal:  Indian J Surg Oncol       Date:  2016-02-04

6.  Adjuvant continuous infusion 5-FU, whole-abdominal radiation, and tumor bed boost in high-risk stage III colon carcinoma: a Southwest Oncology Group Pilot study.

Authors:  C Fabian; S Giri; N Estes; C M Tangen; E Poplin; S Vogel; W Goodwin; S Rivkin; T R Fleming; J S Macdonald
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-05-15       Impact factor: 7.038

7.  Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.

Authors:  Vic J Verwaal; Serge van Ruth; Eeclo de Bree; Gooike W van Sloothen; Harm van Tinteren; Henk Boot; Frans A N Zoetmulder
Journal:  J Clin Oncol       Date:  2003-10-15       Impact factor: 44.544

8.  Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study.

Authors:  Dominique Elias; François Gilly; Florent Boutitie; François Quenet; Jean-Marc Bereder; Baudouin Mansvelt; Gérard Lorimier; Pierre Dubè; Olivier Glehen
Journal:  J Clin Oncol       Date:  2009-11-16       Impact factor: 44.544

9.  Poor outcome after cytoreductive surgery and HIPEC for colorectal peritoneal carcinomatosis with signet ring cell histology.

Authors:  T R van Oudheusden; H J Braam; S W Nienhuijs; M J Wiezer; B van Ramshorst; P Luyer; I H de Hingh
Journal:  J Surg Oncol       Date:  2014-09-05       Impact factor: 3.454

10.  Individual lymph nodes: "See it and Zap it".

Authors:  Dennis Winkel; Anita M Werensteijn-Honingh; Petra S Kroon; Wietse S C Eppinga; Gijsbert H Bol; Martijn P W Intven; Hans C J de Boer; Louk M W Snoeren; Jochem Hes; Bas W Raaymakers; Ina M Jürgenliemk-Schulz
Journal:  Clin Transl Radiat Oncol       Date:  2019-03-30
View more
  1 in total

Review 1.  Building a Personalized Medicine Infrastructure for Gynecological Oncology Patients in a High-Volume Hospital.

Authors:  Nicolò Bizzarri; Camilla Nero; Francesca Sillano; Francesca Ciccarone; Marika D'Oria; Alfredo Cesario; Simona Maria Fragomeni; Antonia Carla Testa; Francesco Fanfani; Gabriella Ferrandina; Domenica Lorusso; Anna Fagotti; Giovanni Scambia
Journal:  J Pers Med       Date:  2021-12-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.